vTv Therapeutics Inc. Shareholders' Equity
vTv Therapeutics Inc. (VTVT) had Shareholders' Equity of $78.63 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $78.63M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $89.96M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $64.44M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $70.54M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $78.63M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $89.96M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $64.44M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $70.54M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.76M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $7.92M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $12.20M 10-K · filed 2026-03-10 |
| 2024-09-30 | $15.01M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $16.48M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $20.80M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$24.68M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$25.23M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$25.28M 10-Q · filed 2023-11-09 |
| 2023-03-31 | -$19.19M 10-Q · filed 2023-08-11 |
| 2022-12-31 | -$10.74M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$16.57M 10-Q · filed 2023-11-09 |
| 2022-06-30 | -$8.53M 10-Q · filed 2023-11-09 |
| 2022-03-31 | -$8.09M 10-Q · filed 2023-08-11 |
| 2021-12-31 | -$9.74M 10-K · filed 2024-03-13 |
| 2021-09-30 | -$21.55M 10-Q · filed 2022-11-10 |
| 2021-06-30 | -$47.82M 10-Q · filed 2022-11-10 |
| 2021-03-31 | -$56.27M 10-Q · filed 2022-08-15 |
| 2020-12-31 | -$80.10M 10-K · filed 2024-03-13 |
| 2020-09-30 | -$51.37M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$69.53M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$61.82M 10-Q · filed 2021-08-04 |
| 2019-12-31 | -$49.02M 10-K · filed 2023-03-06 |
| 2019-09-30 | -$47.15M 10-Q · filed 2020-11-05 |
| 2019-06-30 | -$49.90M 10-Q · filed 2020-11-05 |
| 2019-03-31 | -$57.73M 10-Q · filed 2020-08-03 |
| 2018-12-31 | -$82.85M 10-K · filed 2022-03-29 |
| 2018-09-30 | -$43.98M 10-Q · filed 2019-10-30 |
| 2018-06-30 | -$71.60M 10-Q · filed 2019-10-30 |
| 2018-03-31 | -$148.79M 10-Q · filed 2019-07-31 |
| 2017-12-31 | -$151.05M 10-K · filed 2021-02-24 |
| 2017-09-30 | -$136.30M 10-Q · filed 2017-11-01 |
| 2017-06-30 | -$106.41M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$123.47M 10-Q · filed 2017-05-03 |
| 2016-12-31 | -$90.94M 10-K · filed 2020-02-21 |
| 2016-09-30 | -$111.24M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$79.52M 10-Q · filed 2016-08-02 |
| 2016-03-31 | -$63.02M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$77.97M 10-K · filed 2019-02-26 |
| 2015-09-30 | -$94.19M 10-Q · filed 2015-11-13 |
| 2014-12-31 | -$498.81M 10-K · filed 2018-02-27 |
| 2013-12-31 | -$303.73M 10-K · filed 2017-02-24 |
| 2012-12-31 | -$180.17M 10-K · filed 2016-03-04 |